Next Century Growth Investors LLC Grows Stock Holdings in HealthEquity, Inc. $HQY

Next Century Growth Investors LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 31.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 129,465 shares of the company’s stock after buying an additional 31,197 shares during the period. Next Century Growth Investors LLC owned about 0.15% of HealthEquity worth $13,563,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Qube Research & Technologies Ltd bought a new stake in shares of HealthEquity in the 2nd quarter worth approximately $7,878,000. Cerity Partners LLC grew its stake in shares of HealthEquity by 82.4% during the second quarter. Cerity Partners LLC now owns 27,404 shares of the company’s stock valued at $2,871,000 after buying an additional 12,381 shares during the last quarter. Jump Financial LLC purchased a new position in shares of HealthEquity in the second quarter worth about $449,000. Bosun Asset Management LLC purchased a new position in shares of HealthEquity in the second quarter worth about $431,000. Finally, Amundi boosted its holdings in HealthEquity by 9.3% during the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after acquiring an additional 2,574 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have weighed in on HQY shares. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. KeyCorp lowered their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. JPMorgan Chase & Co. boosted their price objective on shares of HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. Finally, Barrington Research reiterated an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a report on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $120.27.

Insiders Place Their Bets

In other news, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the sale, the executive vice president owned 49,795 shares in the company, valued at $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, November 20th. The stock was sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the transaction, the executive vice president owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. The trade was a 1.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 10,781 shares of company stock worth $1,016,707. Insiders own 1.50% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY stock opened at $93.26 on Wednesday. The company’s fifty day moving average price is $96.28 and its 200-day moving average price is $96.71. The stock has a market cap of $7.97 billion, a PE ratio of 42.78, a price-to-earnings-growth ratio of 1.35 and a beta of 0.18. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. The business had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business’s revenue was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.